Journal for ImmunoTherapy of Cancer (Nov 2020)

632 HPN601 is a protease-activated EpCAM-targeting T cell engager with an improved safety profile for the treatment of solid tumors

  • Richard Austin,
  • Thomas Evans,
  • Jack Lin,
  • Sony Rocha,
  • Kathryn Kwant,
  • Maria Dayao,
  • Tessie Ng,
  • Wade Aaron,
  • Evan Callihan,
  • Maria Gamez-Guerrero,
  • Golzar Hemmati,
  • Kevin Wright,
  • Manasi Barath,
  • Yinghua Xiao,
  • Master Degree,
  • Timothy Yu,
  • Patrick Chew,
  • Jessica O’Rear,
  • Scott Gatto,
  • Michael Cremin,
  • Stephen Yu,
  • Purbasa Patnaik,
  • Avneel Hundal,
  • Bryan Lemon,
  • Holger Wesche

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0632
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.